Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leu-M1 immunoreactivity and phaeochromocytoma

L Masmiquel1, M Castro-Forns, I de Torres

  • 1Department of Endocrinology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Journal of Clinical Pathology
|February 1, 1997
PubMed
Summary

Leu-M1 expression is common in phaeochromocytoma, a type of adrenal tumor. However, this marker does not predict malignancy and is mainly influenced by tumor size.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid and possibly nongenomic effects of testosterone on isolated and perfused rat heart.

Proceedings of the Western Pharmacology Society·1998
Same author

[Yield of xenodiagnosis and PCR in the evaluation of specific chemotherapy of Chagas' disease in children].

Boletin chileno de parasitologia·1998
Same author

[Percutaneous suprapubic bladder lithotripsy].

Annales d'urologie·1998
Same author

Factors associated with outcome in major depression: a 6-month prospective study.

Social psychiatry and psychiatric epidemiology·1998
Same author

[Simultaneous transplantation of fetal mesencephalic cells to the striatum and globus pallidus of rats with lesions induced by 6-hydroxydopamine].

Revista de neurologia·1998
Same author

Signs of glaucoma in rhesus monkeys from a restricted gene pool.

Journal of glaucoma·1998

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Phaeochromocytoma is a neuroendocrine tumor of the adrenal medulla.
  • Prognostic factors for phaeochromocytoma are crucial for patient management.
  • Leu-M1 is a cell surface antigen expressed on various cells, including some tumors.

Purpose of the Study:

  • To investigate the prognostic value of Leu-M1 immunoreactivity in phaeochromocytoma.
  • To correlate Leu-M1 expression patterns with clinical and pathological features of phaeochromocytoma.

Main Methods:

  • Analyzed 17 phaeochromocytomas from 15 patients using anti-Leu-M1 monoclonal antibodies.
  • Employed avidin-biotin technique for immunohistochemical staining.
  • Correlated Leu-M1 expression with tumor histology, patient demographics, and clinical outcomes.

Related Experiment Videos

Main Results:

  • Leu-M1 immunoreactivity was detected in 70.5% of phaeochromocytomas.
  • Observed three patterns: isolated, focal, and diffuse.
  • Malignant phaeochromocytomas showed positivity, but no specific pattern predicted malignancy.
  • All multiple endocrine neoplasia type 2A (MEN 2A) cases were positive.
  • Diffuse Leu-M1 pattern correlated with tumors larger than 7 cm.

Conclusions:

  • Leu-M1 expression is frequent in phaeochromocytoma.
  • Leu-M1 immunoreactivity is not a reliable predictor of malignant behavior in phaeochromocytoma.
  • Tumor size appears to be a significant factor influencing Leu-M1 expression patterns.